The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives

Newborn screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone by immunoassay remains controversial despite screening been available for almost 40 years. Screening is confounded by poor immunoassay specificity, fetal adrenal physiology, stress, and illness which can result in a la...

Descripción completa

Detalles Bibliográficos
Autores principales: de Hora, Mark, Heather, Natasha, Webster, Dianne, Albert, Benjamin, Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578435/
https://www.ncbi.nlm.nih.gov/pubmed/37850096
http://dx.doi.org/10.3389/fendo.2023.1226284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578435/
https://www.ncbi.nlm.nih.gov/pubmed/37850096
http://dx.doi.org/10.3389/fendo.2023.1226284

Ejemplares similares